Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorStanford University

About this trial

We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.

Eligibility criteria

Qualifiers

Males or females 18 years of age or older and 70 years of age or younger at the time of the first Screening Visit.

American Society of Anesthesiologists (ASA) Physical Status Classification System 1 or 2 (1-A normal healthy patient or 2-A patient with mild systemic disease)

For women of childbearing potential, negative urine pregnancy test within 7 days of Screening Visit. Willingness to use highly effective contraception during the entire study period (e.g.: implants, injectables, oral contraceptives, intra-uterine device or declared abstinence).

Subject is fluent in English and understands the study protocol and informed consent and is willing and able to comply with study requirements and sign the informed consent form.

Disqualifiers

Prior gastric or esophageal surgery, including lap banding or bariatric surgery

Bowel obstruction

Gastric outlet obstruction

Diverticulitis

Trial design

Treatments tested in this trial

  • Microbiota Sampling

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators